Clinical Trial Update: Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma [NA]

View source ↗

Summary

An ongoing clinical trial update for the Resource Intervention to Support Equity (RISE) study in high-risk neuroblastoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-risk Neuroblastoma
• Neuroblastoma

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Neuroblastoma, High-risk Neuroblastoma | NA | Status: RECRUITING